In recent years, with the aging of the population and the continuous release of primary medical care , China's pharmaceutical industry has entered an accelerated period of development. According to the data of Yiou.com, in 2016, China's pharmaceutical industry enterprises above designated size achieved a revenue of RMB 29,635.86 billion, a year-on-year increase of 9.92%. The growth rate was 0.90 percentage points higher than the same period of the previous year. The growth rate was higher than the national industry's overall growth rate of 5.02. Percentage points. Among them, among the sub-sectors, the fastest growing is the manufacture of medical instruments and equipment, and the growth rate of chemical raw materials, proprietary Chinese medicines and pharmaceutical equipment is lower than the industry average, but it is also steadily moving forward. In 2018, it was called "the year of generic evaluation of generic drugs" by the industry. With the gradual end of the protection period of a batch of heavyweight patented drugs, the market share of generic drugs has expanded rapidly, and affected by the favorable policies, China's generic drug market is expected to usher in a period of explosive growth. But at the same time, it faces new pressures and challenges, and environmental protection is a major obstacle. On January 1, 2018, the Environmental Protection Tax Law was officially implemented. Since the pharmaceutical industry is a highly polluting and high environmental risk fine chemical industry, the pollutants it produces can cause serious harm to human health and the natural environment. Industry insiders expect that, in this context, on the one hand, some pharmaceutical companies may be restricted or discontinued due to pollution rectification, and on the other hand, small and medium-sized pharmaceutical enterprises that are unable to upgrade equipment and environmental protection may face elimination. At the same time, upgrading environmentally friendly medical equipment will also become the trend of the times. According to the report released by China Industrial Research Network, from the perspective of the market structure of the Chinese medicine industry, the Chinese patent medicine industry will become the sub-sector with the largest share of the Chinese medicine market. The environmentally-friendly Chinese patent medicine manufacturing equipment will inevitably receive the attention and attention of the industry. Taking the traditional Chinese medicine decoction piece industry as an example, in recent years, China has mandated that Chinese medicine decoction pieces production enterprises meet GMP standards, and encourage Chinese medicine enterprises to carry out mergers and acquisitions. Some pharmaceutical enterprises with small scale and unregulated management will gradually withdraw from the market. With the continuous development of the industry and the improvement of the competitiveness of competitive enterprises, the concentration of Chinese medicine decoction pieces industry will gradually increase, and the demand and requirements for related Chinese medicine decoction pieces processing equipment will continue to increase. Common Chinese medicine processing equipment, such as decocting machine, slicer, microwave dryer, pulverizing equipment, etc., have a large share in the Chinese traditional medicine processing equipment market. In recent years, these industries have been continuously developed, and the number of enterprise manufacturers has been expanding. Production processes and technologies are constantly being upgraded and improved, and market competition is becoming increasingly fierce. In the new year, with the continuous deepening of the concepts of energy conservation and environmental protection, green, environmentally friendly, energy-saving and efficient Chinese medicine processing equipment is expected to gain market favor. This also promotes the withdrawal of traditional and backward production technology and production equipment from the market. It is necessary for Chinese medicine processing equipment manufacturers to seize the development trend and carry out the necessary transformation and upgrading of equipment to help China's proprietary Chinese medicine industry develop better. GMP ATS Injection, Tetanus Antitoxin, Tetanus Toxoid ,Tetanus Antitoxin Injection, Antitetanus, Refined Tetanus Antitoxinsupplier in China Tetanus Antitoxin,Tetanus Toxoid,Tetanus Antitoxin Injection,Antitetanus&Refined Tetanus Antitoxin FOSHAN PHARMA CO., LTD. , https://www.fspharmaapi.com
The “three wastes†(ie, waste water, waste gas, and waste residue) produced by pharmaceutical companies in the production process are large in quantity and complex in composition, and often have the characteristics of toxicity, irritancy, corrosiveness, and serious noise. Its governance cost is large, and the recycling rate is low. However, the environmental protection tax is levied, and the pharmaceutical companies that are the major emitters of “three wastes†will inevitably bear heavy pressure.